Clinical trial
Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases
NCT02992249 is registered in ClinicalTrials.gov with Avita Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases
- Lead sponsor
- Avita Medical
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- June 30, 2020
- Enrollment
- 100 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.